Results 201 to 210 of about 19,784 (215)

Effect of Dipeptidyl Peptidase-IV (DPP-IV) Inhibitor (Vildagliptin) on Peripheral Nerves in Streptozotocin-induced Diabetic Rats

Archives of Medical Research, 2009
Tae Sun Park, Heung Yong Jin, Wei Jing Liu   +2 more
exaly  

Octreotide for hypoglycemia caused by sulfonylurea and DPP-4 inhibitor

Diabetes Research and Clinical Practice, 2015
Hisamitsu Ishihara, Masanori Abe, Suguru Yamaguchi   +2 more
exaly  

Linagliptin: A New DPP-4 Inhibitor for the Treatment of Type 2 Diabetes Mellitus

Postgraduate Medicine, 2011
Peter Tóth
exaly  

Sitagliptin (DPP-4 Inhibitor)-induced Rheumatoid Arthritis in Type 2 Diabetes Mellitus: A Case Report

Internal Medicine, 2012
Naoya Igaki
exaly  

A novel DPP-4 inhibitor teneligliptin scavenges hydroxyl radicals: In vitro study evaluated by electron spin resonance spectroscopy and in vivo study using DPP-4 deficient rats

Metabolism: Clinical and Experimental, 2016
Toshihide Yamasaki, Toyoshi Inoguchi, Noriyuki Sonoda   +2 more
exaly  

Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes

ACS Medicinal Chemistry Letters, 2014
Jun Xu
exaly  

DPP-4 inhibitor impedes lipopolysaccharide-induced osteoclast formation and bone resorption in vivo

Biomedicine and Pharmacotherapy, 2019
Aseel Marahleh, Hideki Kitaura, Jiawei Qi   +2 more
exaly  

An effective treatment approach of DPP-IV inhibitor encapsulated polymeric nanoparticles conjugated with anti-CD-4 mAb for type 1 diabetes

Drug Development and Industrial Pharmacy, 2018
Ashish Wadhwani, Hanumant Singh Rathore, Pavan Kumar Chintamaneni   +2 more
exaly  

Design and synthesis of DPP-4 inhibitor for the treatment of type 2 diabetes

Chinese Chemical Letters, 2010
exaly  

Management of a Prediabetes Case With the DPP-4 Inhibitor Sitagliptin

Annals of Pharmacotherapy, 2014
Jeremy Johnson, Katherine S O'Neal
exaly